126 - 150 of 195
Number of results to display per page
AuthorTitleSubjectDatePublication Type
126 Sandoval, Ver©nicaMethylphenidate, the vesicular monoamine transporter-2 and neurotoxicityPhysiology; Dopamine2002-05dissertation
127 Koch, MichaelMode of action of exocarpic acid against mycobacterium tuberculosisMycobacterium tuberculosis; Antibacterial Agents2010-04-21dissertation
128 Downs, John EdwardModel for patient monitoring in community pharmacyDrug Monitoring; Pharmaceutical Services1993-12thesis
129 Jay, Julie IModification of the phenylboronate-diol crosslink: applications in pH-responsive vehicles and synthetic lectin for women controlled HIV preventionDrug Delivery Systems; HIV Infections; AIDS (Disease)2010-02-19dissertation
130 Bakhit, Ivan CharlesModulation of biogenic amine enzymesPsychotropic drugs; Neurotransmitters; Enzyme inhibitors; Amines in the body1980-06dissertation
131 Sudweeks, Sterling NobleMolecular and functional properties of the gamma-aminobutyric acid type A receptorGABA - Receptors1997-12dissertation
132 Vargas, Jay R.Morphological and functional alterations of astrocytes following experimental induced epilepsy2011-12dissertation
133 Stone, Donna MarieNeurochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) : role of endogenous dopamine and oxidative damage in the immediate and longterm inactivation of rat central tryptophan hydroxylasePharmacology; Toxiticity1988-12dissertation
134 Franz, Donald NorbertNeuropharmacological studies of the sympathetic reflex arc1966-08thesis
135 Marik, Purba SwapankumarNeurosteroid modulation of GABAa receptorsPhysiology2005-12thesis
136 Woessner, David W.New strategies for targeted chronic myeloid leukemia therapy: disrupting BCR-ABL1 dimerization and secondary leukemia-specific pathways2013-12dissertation
137 Smiley, Patricia LouiseNovel neutrophil agonists : oxidatively-fragmented phosphatidylcholinesImmunology1992-08dissertation
138 Dean, Robin RebeccaOpiate receptor down-regulation and tolerancePharmacokinetics1986-08dissertation
139 Harmsworth, Wendy LynnOrgan and enzyme selectivity and toxicological significance of cytochrome P450 induction and inhibition elicited by nitrogen heterocyclesKidney; Liver; Metabolism; Xenobiotics; Pharmacokinetics; Pharmacology; Polycyclic Hydrocarbons; Toxicology1991-03dissertation
140 Klein, Brian DonaldPathophysiology associated with a single gene (MASS1) mutation underlying the robust audiogenic seizure phenotype in Frings miceGenetics2003-05dissertation
141 Rice, Robert DavidPatterns of signs, symptoms, and cytokines during the engraftment phase of autologous stem cell transplantationAutotransplantation; Stem Cells2010-02-03dissertation
142 Spence, Russell AllenPerformance appraisal of decentralized pharmacists1988-06thesis
143 Allen, Kay HislopPharmacist instruction and patient compliance with medication therapyMedication Error; Patient Instruction1974-03thesis
144 Bevans, Tatjana S.Pharmacokinetic and pharmacodynamic implications of inhaled ester-based anesthetic agents2016-08dissertation
145 Turkanis, Stuart Allen.Pharmacological and physiological properties of denervated mammalian skeletal muscle.Physiology; Fibrillatory Activity1967-06thesis
146 Kwon, Sun HyungPharmacological approach for inhibition of neointimal hyperplasia associated with arteriovenous hemodialysis graft stenosis2014-08dissertation
147 Weaver, Lawrence Clayton.The pharmacology of anticonvulsant drug combinations.Pharmacology; Drug Combinations2008-02-01thesis
148 Stockmann, ChrisPharmacometric benchmarking: quantitative methods to assess the predictive performance of population pharmacokinetic modeling programs2016-05dissertation
149 Jones, Jeffrey A.Pharmacy leaders and the entry-level Doctor of PharmacyMinimal Educational Level; Pharmacy Profession1993-06thesis
150 Engstrom, Fae LouisePhysiological and neurochemical differences between audiogenic and nonaudiogenic seizure miceConvulsions; Water-Electroyte Balance (Physiology)1985-12dissertation
126 - 150 of 195